Key Highlights
- Ark Invest acquired more than 705K Rocket Lab shares valued at approximately $45M, positioning space technology as the fund’s primary focus area
- The fund purchased 28,589 Robinhood Markets shares worth $3.5M, marking a strategic reversal after the stock surged over 30% in recent weeks
- Palantir and Tempus AI experienced the largest reductions, totaling $25M and $27.7M in sales respectively
- Robinhood Chain’s daily revenue skyrocketed from under $200K to $4M in early September, leading Deutsche Bank to elevate its price target to $136
- The Ark Innovation ETF has delivered a five-year annualized return of -7.02%, trailing the S&P 500’s 11.22% performance over the identical timeframe
Last week witnessed Cathie Wood’s Ark Invest executing strategic portfolio adjustments, increasing exposure to space exploration, financial technology, cryptocurrency, and biotechnology sectors while reducing positions in technology and healthcare companies.
Major Acquisitions by Ark
The space sector dominated the fund’s investment strategy. Ark accumulated more than 705,000 Rocket Lab shares representing approximately $45 million in value. Within the fintech space, the fund secured 456,000 Block shares valued at roughly $37 million.
Additionally, Ark purchased 28,589 Robinhood Markets shares worth approximately $3.5 million. This acquisition represents a complete reversal from previous selling activity, which included divesting 25,009 shares on August 26 and conducting more substantial reductions in July.
Within the biotechnology sector, Ark accumulated 274,000 Intellia Therapeutics shares valued at roughly $3.5 million, complemented by smaller stakes in Veracyte, Guardant Health, and Scribe Therapeutics.
Regarding cryptocurrency exposure, Ark acquired 35,000 Circle Internet Group shares worth approximately $3.3 million and established a position in the 3iQ Solana Staking ETF.
Portfolio Reductions
Ark’s most significant reductions targeted technology and healthcare holdings. Palantir Technologies was reduced by $25 million. Shopify experienced a $23.6 million reduction, while Advanced Micro Devices was trimmed by $8.1 million.
Within healthcare, Tempus AI was reduced by $27.7 million and Twist Bioscience by $11.9 million. Ark also decreased positions in Deere and Roblox by lesser amounts.
Robinhood’s Performance and Bitcoin Connection
Robinhood shares have appreciated more than 30% during the past month, closely following Bitcoin’s 23% climb toward $80,000. The stock had previously declined below $70 during Q2 when Bitcoin hovered around $68,000.
On September 4, Deutsche Bank analyst Brian Bedell increased his Robinhood price target from $115 to $136 while maintaining a buy rating. His optimism stemmed from impressive growth in Robinhood Chain, the company’s proprietary blockchain infrastructure.
Through mid-August, Robinhood Chain generated daily revenue below $200,000. However, revenue dramatically escalated to $3.38 million on September 1 and reached $4.01 million on September 2, based on DeFiLlama analytics.
Deutsche Bank currently projects that Robinhood Chain revenue will surpass a $100 million annualized run rate moving forward.
Robinhood currently represents the seventh-largest position in Ark Innovation ETF, comprising 4.28% of total fund assets.
Wood has publicly advocated for Bitcoin, characterizing it as “a technology revolution” and “a new global monetary system.” She suggested Bitcoin could function as both a risk-on and risk-off investment vehicle as disruptive innovations transform the economic landscape.
As of September 4, Ark Innovation ETF has gained 12.09% year-to-date, marginally trailing the S&P 500’s 12.75% advance during the same timeframe. Over a five-year period, the fund has delivered a -7.02% annualized return, compared to the S&P 500’s 11.22% performance.
The fund experienced approximately $1.71 billion in net outflows during the 12-month period ending September 3.





